AKT1 and colorectal cancer: The enriched PI3K/Akt pathway has also been consistently reported as a typically targeted pathway for baicalein in many studies, including pancreatic [33], esophageal squamous [31], melanoma [40], breast [36], and colorectal cancers [41].